Enhancement of gastric emptying of solids by erythromycin in patients with Roux-en-Y gastrojejunostomy.

Authors:
  • JVJohn Sophocles Vassilakis
    John Sophocles Vassilakis
  • NKNikolaos Karkavitsas
    Nikolaos Karkavitsas
  • GTGeorge Tzovaras
    George Tzovaras
  • EEEmmanuel Epanomeritakis
    Emmanuel Epanomeritakis
  • JTJohn Tsiaoussis
    John Tsiaoussis
  • EXEvaghelos Xynos
    Evaghelos Xynos
Publisher website
Google Scholar
Abstract
Background Roux-en-Y reconstruction is sometimes associated with symptoms that suggest food stasis, as a result of dysmotility of either the gastric remnant and/or the efferent jejunal limb. Objective To study the possible effect of intravenous erythromycin lactobionate on gastric emptying of solids in patients who have undergone a Roux-en-Y procedure. Patients Twenty-four patients with a Roux-en-Y procedure participated in the study. Ten of them had undergone truncal vagotomy with pyloroplasty; the remaining 14 had undergone a Billroth II subtotal gastrectomy as the initial antiulcer procedure. Sixteen healthy subjects served as controls. Methods All healthy subjects and patients underwent assessment of gastric emptying of a standard radiolabeled solid meal after administration of placebo or 200 mg of erythromycin lactobionate intravenously. Scanning was done with a gamma camera, and emptying curves were constructed. From these curves the half-time of gastric emptying was calculated. Results Patients with severe symptoms of gastric stasis had a significantly longer half-time than did patients with mild or no symptoms (P=.002). Patients with a Billroth II subtotal gastrectomy as the initial antiulcer procedure had a significantly worse grade of symptoms (P=.01) and a significantly prolonged half-time (P=.02) compared with patients with a truncal vagotomy with pyloroplasty as the initial antiulcer procedure. Erythromycin significantly reduced the half-time in the controls (P<.001) and all patients after Roux-en-Y procedure (P<.001). Conclusion Erythromycin could be a useful prokinetic drug in patients with Roux stasis syndrome.

This publication has 13 references indexed in Scilit: